Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Structure and mechanism of taniborbactam inhibition of the cefepime-hydrolyzing, partial R2-loop deletion Pseudomonas -derived cephalosporinase variant PDC-88

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.00078-25Source: DataRank Database

Structure and mechanism of taniborbactam inhibition of the cefepime-hydrolyzing, partial R2-loop deletion Pseudomonas -derived cephalosporinase variant PDC-88 is a research paper published in Antimicrobial Agents and Chemotherapy (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.64)OA: hybridTopics (54)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Vijay Kumar ORCID,Christopher R. Bethel,Magdalena A. Taracila,Brittany Miller,Tsuyoshi Uehara ORCID

Live enrichment

PubMed:40503958 PMC:PMC12217481 OpenAlex:https://openalex.org/W4411238876

National Institute of Allergy and Infectious Diseases

Grant: R01AI063517

Biomedical Advanced Research and Development Authority

Grant: HHSO100201900007C

National Institutes of Health

Grant: 5R01AI063517-13

Challenges in beta-Lactamase Mediated Resistance

FWCI

0.64

Citation Percentile

0.6%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://journals.asm.org/doi/pdf/10.1128/aac.00078-25?download=true

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.00078-25?download=true

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.00078-25

journalhttps://doi.org/10.1128/aac.00078-25

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40503958

Fields of Study

Antibiotic Resistance in BacteriaBacterial Genetics and BiotechnologyEscherichia coli research studies0301 basic medicine03 medical and health sciences

MeSH Terms

CefepimeTazobactamAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesBorinic AcidsCarboxylic AcidsCeftazidimeCephalosporinaseCephalosporinsDrug CombinationsHydrolysisMicrobial Sensitivity TestsPseudomonas aeruginosaAzabicyclo Compoundsbeta-Lactamase Inhibitors

Keywords

CefepimePseudomonadalesPseudomonasPseudomonadaceaeLoop (graph theory)CephalosporinMicrobiologyBiologyChemistryCeftazidimeStereochemistryPseudomonas aeruginosaBacteriaGeneticsAntibioticsMathematicsCombinatoricsAntibiotic ResistanceBeta-lactamsBeta-lactamase InhibitorsTazobactamHydrolysisCarboxylic AcidsMicrobial Sensitivity Testsbeta-LactamasesAnti-Bacterial AgentsCephalosporinsDrug CombinationsBacterial ProteinsMechanisms of ResistanceBorinic AcidsAzabicyclo CompoundsCephalosporinase

Structure and mechanism of taniborbactam inhibition of the cefepime-hydrolyzing, partial R2-loop deletion Pseudomonas -derived cephalosporinase variant PDC-88

FAIR Checklist

Authors (10)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)